INSPIRE-Studie für abdominale Infektionen
Die INSPIRE-ASP-Studie (INtelligent Stewardship Prompts to Improve Real-Time Empiric Antibiotic Selection for Patients) für Bauchinfektionen (ABD).
The INSPIRE Abdominal Infection Trial is a cluster-randomized controlled trial of HCA Healthcare hospitals comparing routine empiric antibiotic stewardship practices with real-time, precision medicine computerized physician order entry (CPOE) smart prompts providing the probability that a non-critically ill adult admitted with abdominal infection is infected with a resistant pathogen.
Note: enrolled "subjects" represent 102 individual HCA Healthcare hospitals that have been randomized into 92 clusters. Hospitals were grouped into the same randomization cluster if they shared campuses or antibiotic stewardship staff.
Studienübersicht
Status
Status
Bedingungen
Bedingungen
Intervention / Behandlung
Intervention / Behandlung
Studientyp
Studientyp
Einschreibung (Tatsächlich)
Einschreibung
Phase
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
California
-
Riverside, California, Vereinigte Staaten, 92501
- Riverside Community Hospital
-
San Jose, California, Vereinigte Staaten, 95124
- Good Samaritan Hospital
-
San Jose, California, Vereinigte Staaten, 95116
- Regional Medical Center of San Jose
-
Thousand Oaks, California, Vereinigte Staaten, 91362
- Los Robles Hospital & Medical Center
-
West Hills, California, Vereinigte Staaten, 91307
- West Hills Hospital & Medical Center
-
-
Colorado
-
Aurora, Colorado, Vereinigte Staaten, 80012
- The Medical Center of Aurora
-
Englewood, Colorado, Vereinigte Staaten, 80113
- Swedish Medical Center
-
Lone Tree, Colorado, Vereinigte Staaten, 80124
- Sky Ridge Medical Center
-
Thornton, Colorado, Vereinigte Staaten, 80229
- North Suburban Medical Center
-
-
Florida
-
Bradenton, Florida, Vereinigte Staaten, 34209
- Blake Medical Center
-
Brandon, Florida, Vereinigte Staaten, 33511
- Brandon Regional Hospital
-
Brooksville, Florida, Vereinigte Staaten, 34613
- Oak Hill Hospital
-
Englewood, Florida, Vereinigte Staaten, 34223
- Englewood Community Hospital
-
Fort Walton Beach, Florida, Vereinigte Staaten, 32547
- Fort Walton Beach Medical Center
-
Ft. Pierce, Florida, Vereinigte Staaten, 34950
- Lawnwood Regional Medical Center
-
Hudson, Florida, Vereinigte Staaten, 34667
- Regional Medical Center of Bayonet Point
-
Jacksonville, Florida, Vereinigte Staaten, 32216
- Memorial Hospital Jacksonville
-
Lake City, Florida, Vereinigte Staaten, 32055
- Lake City Medical Center
-
Largo, Florida, Vereinigte Staaten, 33770
- Largo Medical Center
-
Margate, Florida, Vereinigte Staaten, 33063
- Northwest Medical Center
-
Miami, Florida, Vereinigte Staaten, 33133
- Mercy Hospital
-
Miami, Florida, Vereinigte Staaten, 33175
- Kendall Regional Medical Center
-
Orange Park, Florida, Vereinigte Staaten, 32073
- Orange Park Medical Center
-
Oviedo, Florida, Vereinigte Staaten, 32765
- Oviedo Medical Center
-
Panama City, Florida, Vereinigte Staaten, 32405
- Gulf Coast Regional Medical Center
-
Port Charlotte, Florida, Vereinigte Staaten, 33952
- Fawcett Memorial Hospital
-
Port Saint Lucie, Florida, Vereinigte Staaten, 34952
- St. Lucie Medical Center
-
Sarasota, Florida, Vereinigte Staaten, 34233
- Doctors Hospital of Sarasota
-
St. Petersburg, Florida, Vereinigte Staaten, 33707
- Palms of Pasadena
-
St. Petersburg, Florida, Vereinigte Staaten, 33709
- Northside Hospital
-
St. Petersburg, Florida, Vereinigte Staaten, 33710
- St. Petersburg General Hospital
-
Sun City Center, Florida, Vereinigte Staaten, 33573
- South Bay Hospital
-
Tallahassee, Florida, Vereinigte Staaten, 32308
- Capital Regional Medical Center
-
Tampa, Florida, Vereinigte Staaten, 33609
- HCA Florida South Tampa Hospital
-
Tampa, Florida, Vereinigte Staaten, 33615
- HCA Florida West Tampa Hospital
-
Trinity, Florida, Vereinigte Staaten, 34655
- Medical Center of Trinity
-
West Palm Beach, Florida, Vereinigte Staaten, 33407
- JFK Medical Center - North Campus
-
-
Georgia
-
Dublin, Georgia, Vereinigte Staaten, 31040
- Fairview Park Hospital
-
-
Idaho
-
Idaho Falls, Idaho, Vereinigte Staaten, 83404
- Eastern Idaho Regional Medical Center
-
-
Kansas
-
Overland Park, Kansas, Vereinigte Staaten, 66209
- Menorah Medical Center
-
Overland Park, Kansas, Vereinigte Staaten, 66215
- Overland Park Regional Medical Center
-
Wichita, Kansas, Vereinigte Staaten, 67214
- Wesley Medical Center
-
Wichita, Kansas, Vereinigte Staaten, 67220
- Wesley Woodlawn Hospital & ER
-
-
Kentucky
-
Bowling Green, Kentucky, Vereinigte Staaten, 41204
- TriStar Greenview Regional Hospital
-
-
Louisiana
-
Covington, Louisiana, Vereinigte Staaten, 70433
- Lakeview Regional Medical Center
-
New Orleans, Louisiana, Vereinigte Staaten, 70112
- Tulane Medical Center
-
-
Missouri
-
Independence, Missouri, Vereinigte Staaten, 64057
- Centerpoint Medical Center
-
Kansas City, Missouri, Vereinigte Staaten, 64132
- Research Medical Center
-
Lee's Summit, Missouri, Vereinigte Staaten, 64063
- Lee's Summit Medical Center
-
-
Nevada
-
Las Vegas, Nevada, Vereinigte Staaten, 89109
- Sunrise Hospital & Medical Center
-
Las Vegas, Nevada, Vereinigte Staaten, 89109
- Southern Hills Hospital & Medical Center
-
-
South Carolina
-
Charleston, South Carolina, Vereinigte Staaten, 29406
- Trident Medical Center
-
Myrtle Beach, South Carolina, Vereinigte Staaten, 29572
- Grand Strand Medical Center
-
-
Tennessee
-
Chattanooga, Tennessee, Vereinigte Staaten, 37404
- Parkridge Medical Center
-
Chattanooga, Tennessee, Vereinigte Staaten, 37412
- Parkridge East Hospital
-
Dickson, Tennessee, Vereinigte Staaten, 37055
- TriStar Horizon Medical Center
-
Hendersonville, Tennessee, Vereinigte Staaten, 37075
- TriStar Hendersonville Medical Center
-
Nashville, Tennessee, Vereinigte Staaten, 37203
- TriStar Centennial Medical Center
-
Nashville, Tennessee, Vereinigte Staaten, 37211
- TriStar Southern Hills Medical Center
-
Smyrna, Tennessee, Vereinigte Staaten, 37167
- TriStar StoneCrest Medical Center
-
-
Texas
-
Arlington, Texas, Vereinigte Staaten, 76015
- Medical City Arlington
-
Austin, Texas, Vereinigte Staaten, 78705
- St. David's Medical Center
-
Austin, Texas, Vereinigte Staaten, 78758
- St. David's North Austin Medical Center
-
Brownsville, Texas, Vereinigte Staaten, 78526
- Valley Regional Medical Center
-
Conroe, Texas, Vereinigte Staaten, 77304
- HCA Houston Healthcare Conroe
-
Corpus Christi, Texas, Vereinigte Staaten, 78412
- Corpus Christi Medical Center - Bay Area
-
Corpus Christi, Texas, Vereinigte Staaten, 78412
- Corpus Christi Medical Center - Heart Hospital
-
Corpus Christi, Texas, Vereinigte Staaten, 78412
- Corpus Christi Medical Center - Doctors Regional
-
Dallas, Texas, Vereinigte Staaten, 75230
- Medical City Dallas
-
Denton, Texas, Vereinigte Staaten, 76210
- Medical City Denton
-
El Paso, Texas, Vereinigte Staaten, 79902
- Las Palmas Medical Center
-
El Paso, Texas, Vereinigte Staaten, 79925
- Del Sol Medical Center
-
Fort Worth, Texas, Vereinigte Staaten, 76104
- Medical City Fort Worth
-
Fort Worth, Texas, Vereinigte Staaten, 76177
- Medical City Alliance
-
Frisco, Texas, Vereinigte Staaten, 75034
- Medical City Frisco
-
Houston, Texas, Vereinigte Staaten, 77082
- HCA Houston Healthcare West
-
Irving, Texas, Vereinigte Staaten, 75039
- Medical City Las Colinas
-
Kingwood, Texas, Vereinigte Staaten, 77339
- HCA Houston Healthcare Kingwood
-
Lewisville, Texas, Vereinigte Staaten, 75057
- Medical City Lewisville
-
Live Oak, Texas, Vereinigte Staaten, 78233
- Methodist Hospital Northeast
-
McAllen, Texas, Vereinigte Staaten, 78503
- Rio Grande Regional Hospital Main Campus
-
McKinney, Texas, Vereinigte Staaten, 75069
- Medical City McKinney
-
North Richland Hills, Texas, Vereinigte Staaten, 76180
- Medical City North Hills
-
Pasadena, Texas, Vereinigte Staaten, 77504
- HCA Houston Healthcare Southeast
-
Pearland, Texas, Vereinigte Staaten, 77584
- HCA Houston Healthcare Pearland
-
Plano, Texas, Vereinigte Staaten, 75075
- Medical City Plano
-
Round Rock, Texas, Vereinigte Staaten, 78681
- St. David's Round Rock Medical Center
-
San Antonio, Texas, Vereinigte Staaten, 78229
- Methodist Hospital
-
San Antonio, Texas, Vereinigte Staaten, 78201
- Methodist Hospital Texsan
-
San Antonio, Texas, Vereinigte Staaten, 78212
- Methodist Hospital Metropolitan
-
San Antonio, Texas, Vereinigte Staaten, 78229
- Methodist Hospital | Specialty and Transplant
-
Texas City, Texas, Vereinigte Staaten, 77591
- HCA Houston Healthcare Mainland
-
Weatherford, Texas, Vereinigte Staaten, 76086
- Medical City Weatherford
-
Webster, Texas, Vereinigte Staaten, 77598
- HCA Houston Healthcare Clear Lake
-
-
Utah
-
Ogden, Utah, Vereinigte Staaten, 84405
- Ogden Regional Medical Center
-
-
Virginia
-
Blacksburg, Virginia, Vereinigte Staaten, 24060
- LewisGale Hospital Montgomery
-
Pulaski, Virginia, Vereinigte Staaten, 24301
- LewisGale Hospital Pulaski
-
Reston, Virginia, Vereinigte Staaten, 20190
- Reston Hospital Center
-
Richmond, Virginia, Vereinigte Staaten, 23229
- Henrico Doctors' Hospital
-
Richmond, Virginia, Vereinigte Staaten, 23225
- CJW Medical Center (Chippenham & Johnston Willis Campuses)
-
Salem, Virginia, Vereinigte Staaten, 24153
- LewisGale Medical Center
-
-
Teilnahmekriterien
Zulassungskriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Facility Inclusion Criteria:
- HCA Healthcare hospitals admitting adults for abdominal infection
- Facility use of MEDITECH as their electronic health record system
Facility Exclusion Criteria:
-
Note: unit of randomization is the hospital, however the computerized physician order entry (CPOE) alert intervention will calculate risk estimates for adults age >=18 admitted to non-intensive care unit wards and who are ordered to receive extended-spectrum antibiotics for abdominal infection.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Anzahl der Arme
Waffen und Interventionen
Teilnehmergruppe / ArmTeilnehmergruppe / Arm |
Intervention / BehandlungIntervention / Behandlung |
|---|---|
|
Aktiver Komparator: Arm 1: Routine Care
Continuation of routine antibiotic stewardship strategies. |
Routine Antibiotic Stewardship Arm - Continuation of antibiotic stewardship activities in accordance with national standards. |
|
Aktiver Komparator: Arm 2: INSPIRE Stewardship Bundle
Use of computerized physician order entry (CPOE) smart prompts, clinician feedback, and activities to support CPOE adoption (including education and alignment of CPOE workflows) to guide empiric choice of antibiotics for abdominal infection in the first 3 days of hospitalization. |
Quality improvement intervention that includes (1) computerized physician order entry (CPOE) decision support alert that provides physicians with patient-specific risk estimates for having an abdominal infection due to a multidrug-resistant organism (MDRO) and recommends standard spectrum antibiotics for low risk patients in the first 3 days of hospitalization; (2) clinician feedback reports, and (3) activities to support CPOE adoption (including education and alignment of CPOE workflows). Other antibiotic stewardship activities to continue in accordance with national standards. |
Was misst die Studie?
Primäre Ergebnismessungen
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Extended-Spectrum Days of Antibacterial Therapy (ES-DOT) Per Empiric Day
Zeitfenster: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Extended-spectrum days-of-therapy per empiric day is defined as the summed number of different extended-spectrum antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different extended-spectrum antibiotics administered at least once during each of the first 3 days would yield 6 days of extended-spectrum days-of-therapy. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Sekundäre Ergebnismessungen
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Vancomycin Days of Antibacterial Therapy Per Empiric Day
Zeitfenster: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Vancomycin days-of-therapy per empiric day is defined as the the number of days that vancomycin is received by a patient, averaged over the empiric period, and summed across all participants. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
|
Antipseudomonal Antibiotic Days Of Therapy (ES-DOT) Per Empiric Day
Zeitfenster: First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Days-of-Therapy is a standardized national measure for antibacterial use in hospitals that counts each different antibiotic administered on each calendar day as one day of therapy, regardless of doses given. Antipseudomonal days-of-therapy per empiric day is defined as the summed number of different antipseudomonal antibiotics received per patient each calendar day, beginning at admission. If an admission is less than 3 days, only the number of days the patient is admitted will contribute to the numerator and denominator. For example, 2 different antipseudomonal antibiotics administered at least once during each of the first 3 days would yield 6 days of antipseudomonal days-of-therapy. |
First 3 calendar days of hospitalization for each patient during the 12-month baseline and 12-month intervention periods
|
Andere Ergebnismessungen
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Intensive Care Unit (ICU) Transfer [Safety Outcome 1]
Zeitfenster: Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
Days from hospital admission until transfer to ICU, if that occurs. If it doesn't occur, the number of days is censored (capped) at the patient's hospital discharge or at the end of data collection. Almost all patients will be discharged before the end of trial data collection. |
Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
|
Length-of-stay [Safety Outcome 2]
Zeitfenster: Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
Days from hospital admission until discharge. If the patient remains in the hospital at the end of the trial data collection, the number of days is censored (capped) at that time. Almost all patients will be discharged before the end of trial data collection. |
Duration of hospitalization for each patient during 12-month baseline and 12-month intervention periods
|
|
Extended-Spectrum Days of Therapy With Inpatient Extended-Spectrum (ES) Antibiotic Treatment After Empiric Period
Zeitfenster: 12 months
|
The number of different ES antibiotics received each day, on hospital days ≥4 and ≤14. Note: this outcome is intended for a secondary manuscript |
12 months
|
|
Empiric and Total Antibiotic Costs
Zeitfenster: 12 months
|
Empiric and total antibiotic costs for abdominal infection during hospitalization. Note: this outcome is intended for a secondary manuscript. |
12 months
|
|
Incidence of Hospital-Onset C. Difficile
Zeitfenster: 12 months
|
Hospital-onset C. difficile positive tests (specimen obtained) on hospital days ≥4 and ≤14. Note: this outcome is intended for a secondary manuscript. |
12 months
|
|
Incidence of Hospital-Onset MDRO-Positive Cultures
Zeitfenster: 12 months
|
Newly-detected hospital-onset MDRO-positive cultures on hospital days ≥4 and ≤14. Includes total MDRO and specific MDRO subsets. Note: this outcome is intended for a secondary manuscript. |
12 months
|
Mitarbeiter und Ermittler
Sponsor
Sponsor
Mitarbeiter
Mitarbeiter
Ermittler
Ermittler
- Studienleiter: Shruti Gohil, MD, MPH, UC Irvine Division of Infectious Diseases
- Hauptermittler: Susan Huang, MD, MPH, UC Irvine Division of Infectious Diseases
- Hauptermittler: Richard Platt, MD, MS, Harvard Pilgrim Health Care Institute/Harvard Medical School
Publikationen und hilfreiche Links
Allgemeine Veröffentlichungen
- Gohil SK, Septimus E, Kleinman K, Varma N, Sands KE, Avery TR, Mauricio A, Sljivo S, Rahm R, Roemer K, Cooper WS, McLean LE, Nickolay NG, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith KN, Meador B, Froman A, Eibensteiner K, Hayden MK, Kubiak DW, Burks C, Burgess LH, Calderwood MS, Perlin JB, Platt R, Huang SS. Improving Empiric Antibiotic Selection for Patients Hospitalized With Abdominal Infection: The INSPIRE 4 Cluster Randomized Clinical Trial. JAMA Surg. 2025 Jul 1;160(7):733-743. doi: 10.1001/jamasurg.2025.1108.
- Gohil SK, Avery TR, Kleinman K, Septimus E, Mauricio A, Sands KE, Varma N, Sljivo S, Roemer K, Cooper WS, Poland RE, Weinstein RA, Fakhry SM, Guy J, Moody J, Coady MH, Smith-Sells KN, Hayden MK, Kubiak DW, Burks C, Platt R, Huang SS, Baker MA. Improving Empiric Antibiotic Selection for Patients With Cancer Hospitalized With Infection: Secondary Analysis of the INSPIRE Cluster Randomized Trials. JAMA Netw Open. 2026 Jun 1;9(6):e2616611. doi: 10.1001/jamanetworkopen.2026.16611.
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Studienbeginn
Primärer Abschluss (Tatsächlich)
Primärer Abschluss
Studienabschluss (Tatsächlich)
Studienabschluss
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Zuerst gepostet
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes Update gepostet
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
Andere Studien-ID-Nummern
- PH000763B_ABD
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .